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Abstract
!
The crude extract of the bark of Dehaasia longipe-
dicellata exhibited antiplasmodial activity against
the growth of Plasmodium falciparum K1 isolate
(resistant strain). Phytochemical studies of the
extract led to the isolation of six alkaloids: two
morphinandienones, (+)-sebiferine (1) and
(−)-milonine (2); two aporphines, (−)-boldine (3)
and (−)-norboldine (4); one benzlyisoquinoline,
(−)-reticuline (5); and one bisbenzylisoquinoline,
(−)-O-O-dimethylgrisabine (6). Their structures
were determined on the basis of 1D and 2DNMR,
IR, UV, and LCMS spectroscopic techniques and
upon comparisonwith literature values. Antiplas-
modial activity was determined for all of the iso-
lated compounds. They showed potent to moder-
ate activity with IC50 values ranging from 0.031 to
30.40 µM. (−)-O-O-dimethylgrisabine (6) and
(−)-milonine (2) were the two most potent com-
pounds, with IC50 values of 0.031 and 0.097 µM,
respectively, that were comparable to the stan-
dard, chloroquine (0.090 µM). The compounds
were also assessed for their antioxidant activities
with di(phenyl)-(2,4,6-trinitrophenyl)iminoaza-
nium (IC50 = 18.40–107.31 µg/mL), reducing
power (27.40–87.40%), and metal chelating
(IC50 = 64.30 to 257.22 µg/mL) having good to low
activity. (−)-O‑O-dimethylgrisabine (6) exhibited
a potent antioxidant activity of 44.3% reducing
power, while di(phenyl)-(2,4,6-trinitrophenyl)
iminoazanium and metal chelating activities had
IC50 values of 18.38 and 64.30 µg/mL, respectively.
Thus it may be considered as a good reductant
with the ability to chelate metal and prevent
pro-oxidant activity. In addition to the antiplas-
modial and antioxidant activities, the isolated
compounds were also tested for their cytotoxicity
against a few cancer and normal cell lines.
(−)-Norboldine (4) exhibited potent cytotoxicity
towards pancreatic cancer cell line BxPC-3 with
an IC50 value of 27.060 ± 1.037 µM, and all alka-
loids showed no toxicity towards the normal pan-
creatic cell line (hTERT-HPNE).
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l.Introduction
!
Malaria is an important parasitic disease trans-
mitted to humans by the bite of an infected fe-
male mosquito. Approximately 219 million peo-
ple worldwide are affected by malaria and
600000 deaths in 2010 have been reported in
the World Malaria Report [1]. Malaria remains
one of the most important infectious diseases in
the developing world. In Malaysia, the parasites
Plasmodium falciparum, P. knowlesi, and P. vivaxZahari A et al. Antipare recognized as the common cause of malaria.
Symptoms of malaria include fever, shivering,
joint pain, vomiting, and retinal damage [2].
Global warming could increase malaria by ex-
panding the area in which the ambient tempera-
ture and climate conditions are suitable. This
could lead to the resistance of common antima-
larial drugs such as artemisinin-based mono-
therapies. Parasite resistance to artemisinin has
now been detected in 4 countries: Cambodia,
Myanmar, Thailand, and Vietnam [1]. Thus, therelasmodial and Antioxidant… Planta Med 2014; 80: 599–603
Fig. 1 Structures of isolated compounds from Dehaasia longipedicellata.
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l.is an urgency for research to be done on new antimalarial drugs
from natural resources [3].
Antioxidants are widely used as food additives to provide protec-
tion against oxidative degradation of food by free radicals [3]. In-
sufficient levels of antioxidants or inhibition of the antioxidant
enzymes can cause oxidative stress. The antioxidant activity is
important in the treatment of malaria since oxidative stress is
normally synchronized with a malaria infection [4,5]. Antioxi-
dant activity is believed to act in a synergistic way, protecting
the body against oxidative stress [6]. In our continuing interest
in searching for new and biologically active compounds [7–11],
under the framework of the Malaysian-French scientific collabo-
ration, a survey of several crude extracts from Malaysian plants
has shown that Dehaasia longipedicellata (Ridl.) Kosterm. exhib-
ited promising antiplasmodial activity (IC50 = 1.30 µg/mL). There-
fore, we have embarked on the investigation of the antiplasmo-
dial and antioxidant activities of compounds isolated from D.
longipedicellata. Hence, in this study, we communicate the isola-
tion of alkaloids from the active extract and their bioactivities,
antiplasmodial and antioxidant.
Dehaasia is a member of the Lauraceae family. It is an evergreen
tree of moderate size, with large leaves, found growing in the
western parts of Malaysia, China, and the Philipines [12]. About
35 species of Dehaasia are spreadout worldwide and 9 species
are found in Malaysia [13]. Dehaasia is locally known as “gajus
hutan” or “pekan”, and the timber is durable and used for build-
ing houses. D. longipedicellata is a small tree with leaves that are
apex pointed, blades that are soft and hairy on the undersurface,
and are broadly elliptic to obavate. According to the Sakai of the
Tapah Hills, the fruit is very poisonous. This is the first report on
the antiplasmodial and antioxidant activities of isoquinoline al-
kaloids from Dehaasia.D
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In spite of the large diversity of the compounds which have been
studied phytochemically from the Dehaasia genus [14–17], this
report communicates for the first time the occurrence of (+)-sebi-
ferine (1), (−)-boldine (3), (−)-norboldine (4), (−)-reticuline (5),
and (−)-O-O-dimethylgrisabine (6) in D. longipedicellata
(l" Fig. 1). Structural elucidation was performed with the aid of
spectroscopic methods, notably UV, IR, LCMS, and 1D and
2DNMR (COSY, HMBC, HMQC, and NOESY).Table 1 Antiplasmodial and cytotoxicity activities of isolated compounds from De
IC50†
Compounds K1 A549
(+)-Sebiferine (1) 22.460 > 200
(−)-Milonine (2)  0.097 > 200
(−)-Boldine (3) 2.602 117.570 ± 0.067
(−)-Norboldine (4) 9.284 > 200
(−)-Reticuline (5) < 30.400 > 200
(−)-O-O-dimethylgrisabine (6)  0.031 > 200
Chloroquine  0.090
Artemisinin 0.002
Cisplatin 17.520 ± 1.769
* Results expressed asmean ± SE; † results expressed in µg/mL for extracts and µM for pure co
the standard.
Zahari A et al. Antiplasmodial and Antioxidant… Planta Med 2014; 80: 599–603Based on the potent screening result of the DCE (IC50 = 1.30 µg/
mL), the compounds isolated from the bark of D. longipedicellata
were then subjected to in vitro antiplasmodial evaluation against
a chloroquine-resistant strain of P. falciparum, K1 (l" Table 1).
Among the six compounds evaluated for their antiplasmodial ac-
tivity, (−)-O-O-dimethylgrisabine (6) clearly showed the most
potent in vitro antiplasmodial activity with an IC50 value of
0.031 µM, which was slightly better than the positive control
chloroquine. In addition, (−)-milonine (2) also displayed a strong
inhibition capacity with an IC50 value of 0.097 µM, followed by
(−)-boldine (3), (−)-norboldine (4), (+)-sebiferine (1), and (−)-re-
ticuline (5).
(−)-O-O-dimethylgrisabine (6), a bisbenzylisoquinoline, also
showed a high scavenging activity of free radical DPPH with anhaasia longipedicellata.
A375 BxPC-3 hTERT- HPNE
> 200 93.390 ± 5.564 > 200
> 200 > 200 > 200
112.530 ± 3.484 45.500 ± 2.949 > 200
82.890 ± 9.699 27.060 ± 1.037 > 200
97.600 ± 6.561 82.570 ± 0.844 > 200
82.850 ± 8.735 > 200 > 200
35.900 ± 5.199 26.860 ± 0.993 24.670 ± 0.367
mpounds or standards. Bold numbers indicate most active compounds comparable to
Table 2 Antioxidant activities of
compounds from the bark of De-
haasia longipedicellata.
Compounds IC50 DPPH activity
(µg/mL)
% FRAP IC50 metal chelating
activity (µg/mL)
(+)-Sebiferine (1) 107.31 45.69 185.77
(−)-Milonine (2) 58.07 27.39 214.35
(−)-Boldine (3) 44.84 34.37 257.22
(−)-Norboldine (4) 79.97 52.10 157.16
(−)-Reticuline (5) 50.72 87.43 107.36
(−)-O-O-dimethylgrisabine (6)  18.38 44.31  64.31
Ascorbic acid (standard) 13.69
EDTA (standard) 83.74
BHA (standard) 19.60
Bold numbers indicate most active compounds comparable to the standard.
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l.IC50 of 18.38 µg/mL and a moderate reducing power of 44.31%. It
also showed high metal chelating activity with an IC50 of
64.31 µg/mL. Shi et al. [18] have reported tetrandrine, a bisbenzy-
lisoquinoline, as having antioxidant activity against ROS and SOD.
(−)-Milonine (2), (−)-boldine (3), and (−)-reticuline (5) showed
moderate DPPH and metal chelating activities. Whereas, (−)-nor-
boldine (4) and (+)-sebiferine (1) showed low DPPH activity with
moderate metal chelating activity (l" Table 2).
Plasmodium parasites from malaria infection are synergistic to
high levels of oxidative stress. Oxidative stress will induce the
generation of ROS such as hydrogen peroxide (H2O2), hydroxyl
radical (OH•), and superoxide anion radical (O2•−) [19,20]. The
generation of ROS may lead to erythrocyte membrane damage
and the amount of hydroxyl radical of infected erythrocytes was
twice as much compared with normal erythrocytes [4,21,22]. A
study conducted with 100 Gabonese childrenwith severe P. falci-
parum malaria verified the increase of ROS during acute malaria
[23].
According to several studies, free radicals and ROS are no longer
seen as destructive factors but as messengers, such as for the iron
requirement in the host-parasite interaction for oxygen trans-
port, respiration, and enzyme activities [24–26]. Plasmodium
parasites need iron for survival and replication [27]. Therefore
by having an iron chelating agent, the iron needed for the surviv-
al of the Plasmodiumwill be chelated and suppressed by the anti-
oxidant compound, which could lead to the killing of the Plasmo-
dium parasite [28]. Mabeza et al. [29] have reported on iron che-
lation therapy with flavonoids for malaria patients. Since (−)-O-
O-dimethylgrisabine (6) possess a high chelating activity as part
of its antioxidant effect, it could decrease the presence of iron
and provide a more effective treatment for malaria. The present
study showed that (−)-O-O-dimethylgrisabine (6) exhibited both
iron binding and antiplasmodial activity, and the latter is compa-
rable to chloroquine. Thus, the synergism between antimalarials
and antioxidants exists through metal chelating activity for ma-
laria treatment [30]. Therefore, (−)-O-O-dimethylgrisabine (6)
could be a good candidate for further drug discovery develop-
ment of potential antimalarial agents possessing antioxidant ca-
pability.
All of the isolated compounds showed no potency against lung
(A549) cancer cells and weak cytotoxicity against skin (A375)
cancer cells with IC50 values below 100 µM for (−)-norboldine
(4) (82.890 ± 9.699 µM) and (−)-O‑O-dimethylgrisabine (6)
(82.850 ± 8.735 µM). However, for pancreatic cancer cells (BxPC-
3), a great potency was shown by (−)-norboldine (4) with an IC50
of 27.060 ± 1.037 µM. The same compounds were tested against
normal pancreatic cells (hTERT-HPNE) and no cytotoxicity wasobserved. Therefore, (−)-norboldine (4) should be studied further
as a potential lead for drug discovery in cancer studies (l" Table
1).Materials and Methods
!
General experimental procedures
Spectra were recorded on the following instruments: UV, Shi-
madzu UV-250, UV-visible spectrometer; IR, Perkin Elmer 1600;
NMR, AVN BRUKER with CDCl3 as the solvent. Thesewere used to
obtain the 400MHz for the proton spectrum and 100MHz for the
carbon spectum. Mass spectra were obtained using Agilent Tech-
nologies 6530 accurate-mass Q‑TOF LC/MS, with a ZORBAX
Eclipse XDB‑C18 rapid resolution HT 4.6mm i.d × 50mm×
1.8 µm column. All solvents, except those used for bulk extrac-
tion, are AR grade. Column chromatography separations were
conducted using Merck silica gel 60 (230–400 mesh) and silica
gel 60 F254 for TLC monitoring. Glass and aluminium supported
silica gel 60 F254 plates were used for TLC. TLC spots were visual-
ized under UV light (254 and 365 nm) followed by spraying with
Dragendorffʼs reagent for alkaloid detection. HPLC was per-
formed on a Waters system equipped with a binary gradient
module (Waters 2545), system fluidics organizer (Waters SFO),
photoiodide array detector (190–600 nm, Waters 2998), and a
sample manager (Waters 2767). Chromatographic analysis and
separations were performed on a Chromalith semiprep RP-18
endcapped HPLC column. The samples were eluted at a flow rate
of 4mL/min.
Plant material
The bark of D. longipedicellatawas collected on 29 February 2009
at Sungai Tekam Reserve Forest, Jerantut, Pahang by the phyto-
chemical group of the Department of Chemistry, Faculty of Sci-
ence, University of Malaya. The plant specimen was identified by
Mr. Teo Leong Eng and Mr. Din Mat Nor. A voucher specimen
(KL5634) has been deposited at the Herbarium of the Depart-
ment of Chemistry, University of Malaya, Kuala Lumpur, Malaysia.
Extraction and separation
Dried, grounded bark of D. longipedicellata (2.0 kg) was first de-
fatted with hexane twice for a 3-day period. The hexane extracts
were combined and the solvent was evaporated. The plant mate-
rial was dried up and then soakedwith 25% NH4OH for 2 hours. It
was then macerated twice for a 3-day period with dichlorometh-
ane. DCEwas finally concentrated to give a crude alkaloid extract
of 18.7 g. DCE 10.5 g was subjected to column chromatographyZahari A et al. Antiplasmodial and Antioxidant… Planta Med 2014; 80: 599–603
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l.over silica gel (0.04–0.063mm; 6 × 65 cm) eluting with a mixture
of a dichloromethane:methanol solvent in proportions of 100:0,
99:1, 98:2, 97:3, 96:4, 95 :5, 94:6, 92:8, 90:10, 80:20, 50 :50,
and 0:100, v/v, each 1000mL, in gradient to obtain 7 main frac-
tions (Fr. 1 – Fr. 7) based on their TLC profiles. Further purification
of Fr. 4 by preparative TLC (1.00 g using [CH2Cl2 :MeOH at a ratio
of 97 :3, v/v], saturated with NH4OH; Dragendorff reagent) led to
the isolation of (+)-sebiferine (1) [20mg, Rf: 0.58, ([α]D27 +92.31,
c = 0.00013, MeOH)], (−)-milonine (2) [17mg, Rf: 0.42, ([α]D27
− 109.09, c = 0.00011, MeOH)], and (−)-boldine (3) [10mg, Rf:
0.33, ([α]D27 − 66.67, c = 0.00003, MeOH)]. Preparative TLC of Fr. 5
(80mg [CH2Cl2 :MeOH 96:4, v/v] saturated with NH4OH; Dra-
gendorff reagent) yielded (−)-reticuline (5) [10mg, Rf: 0.38,
([α]D27 − 66.67, c = 0.00003, MeOH)] and Fr. 6 (70mg [CH2Cl2 :
MeOH 96:4, v/v] saturated with NH4OH; Dragendorff reagent)
yielded (−)-O-O-dimethylgrisabine 6 (5mg, Rf: 0.83, ([α]D27
−50.00, c = 0.00004, MeOH)]. Fr. 7 (200mg) was further purified
by HPLC on a Chromolith semiprep RP-18 endcapped (10–
100mm) Merck kGaA columnwith the following solvent system:
acetonitrile + 0.1% formic acid-water + 0.1% formic acid (90:10)
at a flow rate of 4.0mL/min to give (−)-norboldine (4) (10mg,
[α]D27 − 100.00, c = 0.00010, MeOH). The Rf of (−)-norboldine (4)
was 2.00 minutes. The degree of purity of the isolated com-
pounds was determined by 1H NMR spectroscopy and was found
to be 99% for compounds 1, 2, 3, and 4, and 98% for compounds 5
and 6.
Antiplasmodial assay
The DCE and the isolated compounds were evaluated for their in
vitro antiplasmodial activity against P. falciparum strain K1,
which is resistant to chloroquine. Chloroquine (purity 98.0%)
and artemisinin (purity 98.0%) were purchased from Sigma
Chemicals and used as positive controls. Isolated and standard
compounds were maintained in a continuous culture as de-
scribed by Trager and Jensen [31], with some modifications. The
synchronization of the malaria culture to one stage follows the
method of Lambros and Vanderberg [32]. Antiplasmodial activity
was evaluated using a histidine-rich protein II (HRPII) assay from
Noedl et al. [33]. The antiplasmodial activity of each compound
was expressed as an IC50 value, defined as the concentration of
the compound causing 50% inhibition of parasite growth relative
to the untreated control.
Antioxidant assay
DPPH assay: The DPPH antioxidant assay was determined as de-
scribed by Shimada et al. [34]. Briefly, DPPH (1mL, 0.1mM) dis-
solved in ethanol was added to an ethanol solution (3mL) of the
tested compounds at different concentrations (0, 50, 100, 150,
and 200 µg/mL). An equal volume of ethanol was added in the
control test. The mixture was shaken vigorously and allowed to
stand at room temperature for 30min. Then, the absorbance at
517 nm was measured with a UV–VIS spectrophotometer. The
percentage of scavenging of DPPH was calculated using the fol-
lowing equation:
DPPH scavenging effect %ð Þ ¼ A
  A1
A
 100
Where A° is the absorbance of the control reaction and A1 is the
absorbance in the presence of the sample. Ascorbic acid (purity
99.0%) was purchased from Sigma and used as the standard ref-
erence.Zahari A et al. Antiplasmodial and Antioxidant… Planta Med 2014; 80: 599–603Ferric reducing power assay (FRAP): The reducing power was de-
termined using the method of Oyaizu [35]. The tested com-
pounds (0.5mL) dissolved in ethanol at different doses (0, 50,
100, 150, and 200 µg/mL) were mixed with a phosphate buffer
(0.5mL, 0.2M, pH 6.6) and potassium ferricyanide [K3Fe(CN)6]
(0.5mL, 1%). The mixture was then incubated at 50°C for
20min. A portion of trichloroacetic acid (0.5mL, 10%) was added
to the mixture, which was then centrifuged for 10min at
3000 rpm (1000 g). The upper layer of the solution (0.5mL) was
mixed with distilled water (0.5mL) and FeCl3 (0.1mL, 0.1%) for
10min, and then the absorbance was measured at 700 nm in a
spectrophotometer. EDTA (purity 99.0%) was purchased from
Sigma and was used as the standard reference.
Metal chelating activity assay: The chelation of ferrous ions was
estimated according to the method of Dinis et al. [36]. Briefly,
tested compounds dissolved in ethanol (0.95mL, at different
doses of 0, 50, 100, 150, and 200 µg/mL) were added to a solution
of FeCl2 (2mM, 50 µL). The reaction was initiated by the addition
of ferrozine (5mM, 200 µL), and then the mixture was shaken
vigorously and left standing at room temperature for 10min.
After equilibrium was reached, the absorbance of the solution
wasmeasured spectrophotometrically at 562 nm. The percentage
of inhibition of the ferrozine-Fe2+ complex of each sample was
calculated according to the following formula:
% Inhibition = [(abscontrol − abssample)/abscontrol] × 100
where abscontrol = absorbance reading of the control and abs-
sample = absorbance reading of the sample. The IC50 value was
determined from the graph of the percentage of inhibition
against the concentration. BHA (purity 96.0%) was purchased
from Acros organic and was used as the standard reference.
Cytotoxic assay
Cytotoxicity of the compounds was evaluated against three types
of cancer cell lines: lung (A549), skin (A375), and pancreatic
(BxPC-3); and one normal cell line, pancreatic (hTERT-HPNE).
Cell lines were cultured in DMEM media supplemented with
2mM L-glutamine, 10% fetal bovine serum, 50 µg/mL gentamicin,
and 10% penicillin-streptomycin (Pen Strep), maintained in a
37°C humid atmosphere of a 5% CO2 cell incubator.
Cells were plated into 96-well microplates and maintained in the
cell incubator for 24 h. Then, 100 µL of samples were introduced
in triplicate to a final concentration of 0.1–200 µM. Drug stan-
dards were also introduced to a final concentration of 0.03–
2000 µM (cisplatin). Cells were further incubated for 48 h and cell
viability was determined using an MTS assay kit (CellTiter 96®
AQueous One Solution, Promega) according to the manufac-
turerʼs protocol. Microplates were returned to the incubator for
1–2 h and absorbance of the formazan product was read on a mi-
croplate reader at 490 nmwith 690 nm as the background wave-
length (Infinite 200, Tecan). The IC50 values of the samples and
drug standards were determined using dose-response curves,
and statistical analysis using the Studentʼs t-test (p < 0.05) was
performed in Prism 5.02 software (GraphPad Software, Inc.).Acknowledgments
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